Financhill
Buy
63

ICE Quote, Financials, Valuation and Earnings

Last price:
$171.45
Seasonality move :
4.49%
Day range:
$170.59 - $172.71
52-week range:
$124.34 - $177.45
Dividend yield:
1.07%
P/E ratio:
35.88x
P/S ratio:
8.40x
P/B ratio:
3.56x
Volume:
3.9M
Avg. volume:
3.4M
1-year change:
25.15%
Market cap:
$98.5B
Revenue:
$11.8B
EPS (TTM):
$4.78

Analysts' Opinion

  • Consensus Rating
    Intercontinental Exchange has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $189.25, Intercontinental Exchange has an estimated upside of 10.36% from its current price of $171.49.
  • Price Target Downside
    According to analysts, the lowest downside price target is $158.00 representing 7.87% downside risk from its current price of $171.49.

Fair Value

  • According to the consensus of 10 analysts, Intercontinental Exchange has 10.36% upside to fair value with a price target of $189.25 per share.

ICE vs. S&P 500

  • Over the past 5 trading days, Intercontinental Exchange has underperformed the S&P 500 by -1.31% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Intercontinental Exchange does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Intercontinental Exchange has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Intercontinental Exchange reported revenues of $3B.

Earnings Growth

  • Intercontinental Exchange has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Intercontinental Exchange reported earnings per share of $1.21.
Enterprise value:
117.6B
EV / Invested capital:
--
Price / LTM sales:
8.40x
EV / EBIT:
25.92x
EV / Revenue:
10.00x
PEG ratio (5yr expected):
2.55x
EV / Free cash flow:
30.49x
Price / Operating cash flow:
25.60x
Enterprise value / EBITDA:
19.36x
Gross Profit (TTM):
$6.5B
Return On Assets:
2.03%
Net Income Margin (TTM):
23.42%
Return On Equity:
10.29%
Return On Invested Capital:
5.7%
Operating Margin:
36.07%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $9.6B $9.9B $11.8B $2.7B $3B
Gross Profit $5.2B $5.7B $6.5B $1.5B $1.6B
Operating Income $3.7B $4B $4.4B $993M $1.1B
EBITDA $3.5B $4.9B $6.1B $1.1B $1.5B
Diluted EPS $2.57 $4.19 $4.78 $0.64 $1.21
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $87.2B $154.3B $156.9B $85B $89.1B
Total Assets $126.2B $193.5B $194.3B $136.1B $139.4B
Current Liabilities $88B $153.4B $149.2B $84.6B $89.6B
Total Liabilities $106.6B $170.8B $171.6B $110.3B $111.7B
Total Equity $19.6B $22.7B $22.8B $25.8B $27.7B
Total Debt $16.5B $13.9B $18.1B $22.6B $20.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $3.6B $3.5B $4.6B $969M $1.5B
Cash From Investing $677M -$8.8B -$921M $606M -$920M
Cash From Financing -$1.8B -$64.3B $79M -$1.6B $2.8B
Free Cash Flow $3.1B $3.1B $3.9B $806M $1.2B
ICE
Sector
Market Cap
$98.5B
$614.6M
Price % of 52-Week High
96.64%
85.71%
Dividend Yield
1.07%
1.98%
Shareholder Yield
1.99%
3.73%
1-Year Price Total Return
25.15%
8.3%
Beta (5-Year)
1.094
0.555
Dividend yield:
1.07%
Annualized payout:
$1.80
Payout ratio:
37.73%
Growth streak:
8 years

Technicals

8-day SMA
Sell
Level $174.51
200-day SMA
Buy
Level $157.57
Bollinger Bands (100)
Buy
Level 151.73 - 169.55
Chaikin Money Flow
Buy
Level 612.7M
20-day SMA
Sell
Level $172.46
Relative Strength Index (RSI14)
Buy
Level 50.18
ADX Line
Buy
Level 39.15
Williams %R
Neutral
Level -67.1928
50-day SMA
Buy
Level $167.67
MACD (12, 26)
Buy
Level 1.87
25-day Aroon Oscillator
Buy
Level 56
On Balance Volume
Neutral
Level 1B

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.8288)
Sell
CA Score (Annual)
Level (-1.6902)
Buy
Beneish M-Score (Annual)
Level (-2.4553)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (0.3479)
Buy
Piotroski F Score (Annual)
Level (7)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data services segment (24% of net revenue).

Stock Forecast FAQ

In the current month, ICE has received 7 Buy ratings 3 Hold ratings, and 0 Sell ratings. The ICE average analyst price target in the past 3 months is $189.25.

  • Where Will Intercontinental Exchange Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Intercontinental Exchange share price will rise to $189.25 per share over the next 12 months.

  • What Do Analysts Say About Intercontinental Exchange?

    Analysts are divided on their view about Intercontinental Exchange share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Intercontinental Exchange is a Sell and believe this share price will drop from its current level to $158.00.

  • What Is Intercontinental Exchange's Price Target?

    The price target for Intercontinental Exchange over the next 1-year time period is forecast to be $189.25 according to 10 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is ICE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Intercontinental Exchange is a Buy. 7 of 10 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of ICE?

    You can purchase shares of Intercontinental Exchange via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Intercontinental Exchange shares.

  • What Is The Intercontinental Exchange Share Price Today?

    Intercontinental Exchange was last trading at $171.45 per share. This represents the most recent stock quote for Intercontinental Exchange. Yesterday, Intercontinental Exchange closed at $171.49 per share.

  • How To Buy Intercontinental Exchange Stock Online?

    In order to purchase Intercontinental Exchange stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Buy
52
NUTX alert for Apr 2

Nutex Health [NUTX] is down 0.56% over the past day.

Buy
75
CORT alert for Apr 2

Corcept Therapeutics [CORT] is down 7.04% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock